LoginRegister

    Sequent Scientific posts Rs 30.53 crore profit for Q2

    Written by Ruby Khatun Khatun   |  

    New Delhi: Drug firm Sequent Scientific reported a consolidated net profit of Rs 30.53 crore for the quarter ending September 30.


    The company had posted a net loss of Rs 4.44 crore for the corresponding period of the previous fiscal, Sequent Scientific said in a filing to BSE.


    Consolidated total income of the company stood at Rs 271.93 crore for the quarter under consideration as compared to Rs 232.79 crore for the same period previous fiscal.



    In a separate filing, the company said its board has declared an interim dividend of Rs 0.20 per equity share of Rs 2 each.
    equity shareFinancial resultsinterim dividendnet profitpharma newsprofitsecond quarterSeQuent ScientificTotal income
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2020 Minerva Medical Treatment Pvt Ltd

      © 2020 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X